## min read

ADHD in Women vs. Men: Gender Differences & Treatment

By

Sonia Garcia

|

January 28, 2026

Summarize with AI

ADHD in Women vs. Men: Gender Differences & Treatment

Table of Contents

Example H2
Example H3
Example H4
Example H5
Example H6

In a single classroom, two students navigate the same diagnosis, yet they look worlds apart. One boy spins in his chair, shouting out answers and pulling the room’s attention toward him. Across the aisle, a girl stares quietly out the window, her homework forgotten and her mind miles away.

We already know which student will be sent to the counselor first.

Because symptoms are often quieter in girls, boys are diagnosed two to three times more often. In reality, ADHD affects both sexes with nearly equal frequency. This gap reveals a hidden crisis in modern medicine: when we only look for the loudest symptoms, millions of women are left without the support they deserve.

At Amae Health, we specialize in identifying and treating ADHD in women and men by focusing on these subtle distinctions. We understand that an accurate diagnosis requires looking past stereotypes to see how symptoms actually manifest in daily life.

Understanding the nuances of ADHD in women vs. men is about more than just a label. It is the key to selecting the most effective treatment and finally providing the clarity that so many have been waiting for.

Understanding ADHD: Types and Core Symptoms

The Three Types of ADHD

Attention deficit hyperactivity disorder includes three main types, each of which can occur in any person regardless of gender:

  • Hyperactive-impulsive type. It is characterized by a constant need to move, an inability to sit still, and impulsive actions that often occur without considering the consequences.
  • Inattentive type. Previously known simply as attention deficit disorder, this type of ADHD manifests itself through difficulty concentrating, forgetfulness, and difficulty organizing daily activities.
  • Combined type. This type combines symptoms from both of the previous categories and is the most common form of the disorder.

It is essential to understand that anyone can have any ADHD, but male ADHD is more likely to manifest itself through hyperactive-impulsive symptoms that are easily noticeable to others. At the same time, women and girls are more likely to exhibit the inattentive type, whose symptoms are less obvious and often go unnoticed by teachers, parents, and even doctors.

How ADHD Affects Daily Life

ADHD seriously affects all areas of a person's life, creating difficulties at work or school, in personal relationships, and with self-esteem. In the workplace, individuals with this disorder may struggle to meet deadlines, organize tasks, and maintain attention during prolonged meetings.

In relationships, female ADHD can manifest itself through forgetfulness about essential dates, difficulty with household chores, or emotional instability, which creates tension in the family.

Academic performance also suffers, but in different ways for men and women. Boys with ADHD are more likely to receive behavioral remarks and be referred to specialists. Girls, on the other hand, may underachieve for years, with their problems being attributed to laziness or lack of motivation. Self-esteem declines in all individuals, but women often blame themselves for their inability to meet social expectations of organization and order.

ADHD Symptoms by Gender: Key Differences

Male ADHD Symptoms and Presentation

Male ADHD usually manifests itself through external, obvious behavioral symptoms that disrupt order in the classroom or at home. Boys with ADHD often cannot sit still, fidget constantly, get up without permission, and may even run or climb in inappropriate situations.

Impulsivity is expressed through shouting answers, inability to wait for their turn, and frequent interruptions of others during conversations.

Aggressive behavior and outbursts of anger are also more common in male ADHD, especially when the child or adult is frustrated. Boys are more likely to lose things, forget to complete tasks, and engage in risky behavior, including:

  • Reckless driving in adolescence and adulthood
  • Alcohol and drug abuse as a form of self-medication
  • Involvement in fights or other confrontational situations
  • Disregard for safety rules in various situations

These external, destructive symptoms of male ADHD attract the attention of adults and lead to earlier diagnosis, but also create negative attitudes toward the child from teachers and peers.

Female ADHD Symptoms and Presentation

Female ADHD manifests itself in a completely different way, through internal, less noticeable symptoms that often go unnoticed by those around them.

Girls and women with ADHD are more likely to "have their heads in the clouds," immersed in dreams or their thoughts. Their workspaces and personal belongings may be disorganized, but they do not disrupt others or create noise.

Perfectionism becomes an attempt to compensate for internal chaos — women with ADHD may spend excessive amounts of time completing tasks, redoing them over and over again. Emotional sensitivity manifests itself through strong reactions to criticism, frequent mood swings, and a tendency toward anxiety or depression. Social behavior is also different — instead of aggression, women with ADHD are more likely to:

  • Avoid social situations for fear of doing something wrong
  • Feel a constant sense of inadequacy and guilt
  • Procrastinate for fear of not being able to do a task perfectly
  • Have difficulty making decisions even in simple situations

These internal manifestations of female ADHD are often interpreted as personality traits rather than symptoms of a medical condition, leading to significant delays in diagnosis.

Why Male ADHD is Diagnosed More Often

Historical Bias in ADHD Research

The study of ADHD began with observations of hyperactive boys in the 1960s and 1970s. This laid the groundwork for diagnostic criteria that focus on male manifestations of the disorder. Researchers focused on external, destructive symptoms that interfered with the learning process and required immediate intervention.

For many years, ADHD in women and men was not studied as separate phenomena, which led to the creation of diagnostic tools that better identify male-type symptoms. Even modern assessment scales and tests are primarily based on behavioral manifestations that are more characteristic of boys and men.

Questions such as "Does the child often run or climb in inappropriate situations?" or "Does the child interfere with other children during play?" better describe male behavior patterns. At the same time, female symptoms remain outside the scope of standard diagnostics.

Societal Expectations and Gender Norms

Societal expectations play a huge role in how ADHD symptoms are perceived in different genders. Boys' disruptive behavior quickly attracts the attention of teachers, who refer them to the school psychologist or recommend that their parents seek professional help.

Quiet, dreamy girls often do not cause problems in the classroom, so their symptoms are frequently ignored or attributed to personality traits.

Social stereotypes also influence the perception of male ADHD and female ADHD. Girls are expected to be more organized, obedient, and capable of multitasking. Therefore, when they do not meet these expectations, those around them often consider it laziness or a lack of upbringing. Boys, on the other hand, are "forgiven" for some chaos and impulsiveness as standard male traits, but when these behaviors become excessive, they immediately cause concern.

The Impact of Hormones and Biology

Hormonal differences between men and women significantly influence the onset and course of ADHD throughout life. Estrogen, the primary female sex hormone, plays a vital role in regulating dopamine and norepinephrine, neurotransmitters that are disrupted in ADHD. Fluctuations in estrogen levels during the menstrual cycle can lead to worsening symptoms of female ADHD on certain days of the month.

Pregnancy and the postpartum period present unique challenges for women with ADHD. During pregnancy, many medications used to treat ADHD are contraindicated, and hormonal changes can either improve or worsen symptoms. Menopause is often accompanied by a sharp decline in concentration and memory in women who have never suspected they had ADHD.

Testosterone in men, on the other hand, may have a protective effect, helping to maintain more stable dopamine levels. However, male ADHD can also change with age — many men report that hyperactivity decreases into adulthood, but attention and organization problems remain.

Diagnosis and Treatment at Amae Health

At Amae Health, we have developed a specialized approach to ADHD diagnosis that takes into account the differences in symptom presentation between men and women. Our team of experts understands that ADHD in women vs. men requires different assessment methods and diagnostic tools. We use extensive questionnaires that include questions about internal symptoms, emotional regulation, and social functioning. This allows us to identify female ADHD even in cases where symptoms have been missed previously.

Treatment at Amae Health is tailored to gender differences. For women, we consider the impact of the menstrual cycle on medication effectiveness and can adjust dosages during different phases of the cycle. Psychotherapeutic approaches also vary — men often benefit from strategies for managing impulsivity and aggression, while women tend to respond better to techniques for addressing perfectionism, anxiety, and self-esteem.

If you suspect that you or someone close to you has ADHD, contact the specialists at Amae Health. Our experience in identifying female ADHD has already helped hundreds of women receive the correct diagnosis and effective treatment, radically changing their quality of life. Don't let gender stereotypes deprive you of the opportunity to get the help you need — sign up for a consultation today.

Reccomended for you

# min read

MTHFR Gene Mutation: What It Means for Mental Health

By

Sonia Garcia

|

October 17, 2026

Maybe a genetic report flagged it. Maybe a friend, a forum, or a supplement ad told you it could explain your fatigue, your depression, or why medication never quite worked. Now you're wondering what an MTHFR gene mutation actually means for you.

MTHFR variants are extremely common. Most people who carry them have no health effects at all, and research linking them to mental health conditions shows a real but small association, not a cause. Medical experts don't recommend routine testing for them.

What the MTHFR gene does

The MTHFR gene carries instructions for an enzyme called methylenetetrahydrofolate reductase. That enzyme converts folate, a B vitamin, into the active form your body uses to turn the amino acid homocysteine into methionine. According to MedlinePlus Genetics, the active form, 5-methyltetrahydrofolate, is the main form of folate found in blood.

When the enzyme works less efficiently, homocysteine can build up. That's the mechanism behind most of the interest in MTHFR, including the mental health questions.

C677T, A1298C, heterozygous, and homozygous

Most people searching "MTHFR gene mutation" are really asking about two common variants:

  • C677T. The most common and best studied. At position 677 in the gene, the DNA base C is replaced by T. The resulting enzyme is less stable and less active, especially in people with two copies.
  • A1298C. The second common variant. The CDC notes there isn't enough evidence that A1298C on its own significantly affects how the body processes folate.

You inherit one copy of the gene from each parent, which is where the lab terms come from:

  • Heterozygous means one copy carries the variant (for C677T, written CT).
  • Homozygous means both copies carry it (TT).
  • Compound heterozygous means one copy of C677T and one copy of A1298C.

These variants are so common they're closer to normal human variation than to a disease. The CDC reports that more people in the U.S. have one or two copies of C677T than don't. Having both copies is less common: MedlinePlus estimates about 25% of Hispanic people and 10% to 15% of North American white people carry two copies of C677T.

MTHFR symptoms: what the variant does and doesn't cause

Most people with common MTHFR variants have no symptoms. Cleveland Clinic puts it plainly: MTHFR gene variants most often don't affect your health or cause symptoms. When they do matter, it's usually through higher homocysteine or lower folate, and mostly in people with two copies of C677T. Even then, how much folate you get from food matters more than your genotype.

That's different from what you'll read on many wellness sites, which attribute everything from fatigue to brain fog to MTHFR. There's no reliable evidence for a list of "MTHFR symptoms" in people with the common variants. If you have symptoms, they deserve an evaluation, not an assumption that a gene variant explains them.

There is one important exception. Rare, severe mutations in the MTHFR gene cause homocystinuria, a serious inherited condition whose symptoms usually appear early in life. Most U.S. newborns are screened for it shortly after birth. That's a different situation from the common C677T and A1298C variants.

MTHFR and mental health: what research shows

Because MTHFR sits in the folate and methylation pathway, researchers have looked hard for links to psychiatric conditions. The findings are consistent in one way: the effect is modest.

  • Depression. A 2013 meta-analysis of 26 studies, with 4,992 people with depression and 17,082 controls, found that two copies of C677T were associated with higher odds of depression (odds ratio 1.42). The link was stronger in Asian populations, marginal in white populations, and absent in older adults.
  • Schizophrenia, bipolar disorder, and depression combined. A 2011 meta-analysis of case-control studies with 29,502 participants found TT carriers had modestly higher odds of these conditions as a group (odds ratio 1.26). The authors read this as evidence of a shared genetic vulnerability across the three conditions.

An odds ratio of 1.26 to 1.42 is a small increase in relative risk for a very common genotype. Most people with two copies of C677T never develop depression, bipolar disorder, or schizophrenia, and most people with those conditions don't have two copies. Mental health conditions come from many genes and life experiences acting together. MTHFR is, at most, one small piece.

Folate, folic acid, and methylfolate

A common online claim is that people with MTHFR variants can't use folic acid and need "methylated" supplements instead. The CDC says that isn't true: people with an MTHFR variant can process all types of folate, including folic acid. People with the TT genotype have blood folate levels only about 16% lower on average than people with CC at the same intake, and folic acid intake matters more than genotype in determining blood folate.

L-methylfolate, the active form, has been studied as an add-on to antidepressants. In two randomized trials published in the American Journal of Psychiatry in 2012, adults with depression that hadn't responded fully to an SSRI received L-methylfolate or placebo alongside their medication. The first trial, with 148 patients starting at 7.5 mg a day, found no difference. The second, with 75 patients at 15 mg a day, found a significant benefit over placebo. Both enrolled people based on their depression, not on a genetic test. Whether any add-on makes sense for a specific person is a clinical decision that depends on their full history.

For more on how folate and other nutrients relate to mood, see our article on nutrient deficiencies and anxiety.

Should you get tested for MTHFR?

For most people, no. MedlinePlus states that medical experts don't recommend testing for common MTHFR gene changes in most cases. A provider may order it in specific situations, such as high homocysteine on a blood test combined with a family history.

The American College of Medical Genetics and Genomics went further in a 2013 practice guideline: MTHFR polymorphism testing has minimal clinical utility and shouldn't be part of a routine evaluation for blood clotting disorders. Recent meta-analyses had disproven the links that originally motivated the testing.

If you already have a result, it's still useful context to share with your care team. It just isn't a diagnosis, and it isn't a treatment plan.

When depression or mood symptoms don't improve

People often look up MTHFR because something isn't working: depression that keeps coming back, medication that only half helps, or mood swings no one has explained. Those problems are real, even if MTHFR is unlikely to be the answer. They usually call for a fuller psychiatric evaluation: a closer look at the diagnosis, past medication trials, co-occurring conditions, sleep, substance use, and physical health.

That's the kind of care we provide at Amae Health. Our clinics specialize in conditions including Major Depressive Disorder, bipolar disorder, and schizophrenia. Our care teams bring psychiatrists, therapists, primary care physicians, and dietitians under one roof, so lab results, nutrition, and medication history are reviewed together, by people who share one treatment plan. See how our integrated outpatient clinics work.

Frequently asked questions

How common is the MTHFR gene mutation?

Very common. According to the CDC, more people in the U.S. have one or two copies of the C677T variant than don't. Two copies are less common, estimated at about 25% of Hispanic people and 10% to 15% of North American white people.

What are the symptoms of being MTHFR C677T heterozygous?

Usually none. According to MedlinePlus, raised homocysteine is seen mainly in people with two copies of C677T. If you have symptoms, they need an evaluation of their own rather than being attributed to one copy of a common variant.

Does MTHFR cause depression?

No single gene causes depression. Two copies of C677T are associated with modestly higher odds of depression in meta-analyses, with an odds ratio around 1.4, but most people who carry them never develop depression.

Do people with MTHFR need methylfolate instead of folic acid?

According to the CDC, no. People with MTHFR variants can process folic acid, and folic acid intake matters more than genotype for blood folate levels. L-methylfolate has been studied as an add-on treatment for depression, regardless of MTHFR status, and decisions about it belong with a clinician.

Is MTHFR testing worth it?

For most people, it isn't recommended. Medical genetics experts say the common variants have minimal clinical utility. A provider may order testing in specific cases, such as unexplained high homocysteine with a family history.

Key takeaways

  • An MTHFR gene mutation usually means one or two copies of the common C677T or A1298C variants, which most people carry without health effects.
  • Two copies of C677T can raise homocysteine and are linked to modestly higher odds of depression, bipolar disorder, and schizophrenia, but the effect is small.
  • People with MTHFR variants can process folic acid, and routine MTHFR testing isn't recommended.
  • If depression or mood symptoms aren't improving, a full psychiatric evaluation is more useful than a gene result.

If you or someone you love is living with depression, bipolar disorder, or schizophrenia that hasn't responded to treatment, request an intake appointment. Our team will walk you through how an evaluation works and what to bring, including any lab or genetic results you already have.

# min read

Spravato vs Ketamine Infusions: Key Differences

By

Sonia Garcia

|

October 16, 2026

Comparing Spravato vs ketamine infusion treatment means comparing two versions of the same idea: using ketamine's fast action on the brain's glutamate system to treat depression that standard antidepressants haven't relieved. The best comparison so far, a 2025 meta-analysis by Mayo Clinic researchers, found no statistically significant difference in how often the two lead to response or remission. What separates them is everything around the drug: FDA status, how it's given, how quickly it tends to work, what it costs, and who pays.

‍

So far, neither has been shown to be the better drug.

What Is Spravato (Esketamine)?

Esketamine vs ketamine comes down to chemistry. Standard ketamine is an equal mix of two mirror-image forms of the same molecule. Esketamine is one of those forms on its own, and Spravato is esketamine delivered as a nasal spray.

‍

The FDA first approved Spravato in 2019 for treatment-resistant depression, taken together with an oral antidepressant, as the Mayo Clinic review notes. A second approval, again paired with an oral antidepressant, covers depressive symptoms in adults with major depressive disorder who have acute suicidal thoughts or behavior. And the most recent change came in January 2025, when the FDA added standalone use for treatment-resistant depression, as the current prescribing information shows.

‍

Every dose happens in a certified healthcare setting under the Spravato REMS, an FDA-required safety program. Each device delivers 28 mg, and a session uses two or three devices (56 or 84 mg), with a five-minute wait after each one. You're then monitored for at least two hours, and you can't drive again until the next day, once you've had a restful night's sleep. The label sets the early schedule: twice a week for weeks one through four, once a week for weeks five through eight, then weekly or every two weeks, adjusted to the least frequent dosing that maintains the response.

What Is Ketamine Infusion Therapy?

A ketamine infusion uses standard ketamine, both mirror-image forms together, delivered through an IV line. Ketamine has been FDA-approved as an anesthetic since 1970, but for depression, IV ketamine "remains an off-label treatment," in the Mayo Clinic review's words. Off-label prescribing is legal and common in medicine. It also means there is no FDA-approved depression regimen, so dosing schedules and safety protocols are set by each clinic.

‍

The most studied dose is 0.5 mg per kilogram of body weight, infused over about 40 minutes with continuous heart and blood pressure monitoring. A first course typically runs two to three infusions a week for about three to six treatments, followed by maintenance sessions on a schedule that varies from clinic to clinic.

Spravato vs Ketamine Infusion: Side-by-Side Comparison

Feature Spravato (esketamine) IV ketamine infusion
What it contains Esketamine, one mirror-image form of ketamine Ketamine, both mirror-image forms
FDA status for depression Approved for treatment-resistant depression (2019 with an oral antidepressant; monotherapy added January 2025) and for major depressive disorder with acute suicidal thoughts Off-label; FDA-approved as an anesthetic
How it's given Nasal spray you use yourself, under supervision IV line placed by clinic staff
Typical dose 56 or 84 mg per session About 0.5 mg per kg of body weight
Time in the clinic Two or three devices, five minutes apart, then at least two hours of monitoring About 40 minutes of infusion, plus recovery time
Safety rules Federal REMS program; certified settings only Set by each clinic
Adjusting mid-session A dose can't be reduced once it's sprayed The infusion can be slowed or stopped
Early schedule Twice weekly for four weeks, then weekly Two to three times weekly, about three to six treatments
Insurance More consistently covered when criteria are met Often self-pay

Efficacy: What the Research Shows

The most complete head-to-head evidence is the 2025 Mayo Clinic meta-analysis in Therapeutic Advances in Psychopharmacology. The authors identified eight studies with 978 patients in total. Only one was a randomized trial, and it compared IV ketamine with an IV form of esketamine rather than the nasal spray, so the pooled comparison rests on observational studies of IV ketamine versus nasal esketamine.

‍

In those studies, the odds of response were 1.26 times higher with IV ketamine and the odds of remission 1.31 times higher, but neither difference was statistically significant. The authors concluded that the evidence suggests no significant difference in short-term efficacy, with a slight numerical trend favoring IV ketamine.

‍

Speed may be where the two differ. In one Mayo Clinic observational study included in the review, people reached remission after a median of two IV ketamine treatments, compared with seven nasal esketamine treatments. That's a real gap in lived experience. But it comes from observational data, where the people who choose or can access each treatment may differ in ways a study can't fully account for.

‍

So is Spravato better than ketamine infusions? On current evidence, neither has been shown to be. A randomized trial built to settle the question, called EQUIVALENCE, plans to assign 400 people to one treatment or the other for eight sessions over four weeks. Its protocol was published in 2026, and results are not yet available.

FDA Approval and Insurance Coverage

FDA approval changes who pays. Because Spravato has approved indications, insurers can write coverage criteria around it, and they typically require prior authorization and documentation of earlier antidepressant trials. Ketamine infusions for depression are off-label, so coverage is inconsistent, and many people pay out of pocket.

‍

The Spravato vs ketamine cost comparison has a twist. Economic modeling cited in the Mayo Clinic review found nasal esketamine unlikely to be cost-effective compared with IV ketamine from a health-system perspective. Yet an individual patient's out-of-pocket cost for Spravato may be lower, thanks to insurance coverage or manufacturer assistance. Published price estimates vary too widely by dose, frequency, and coverage to quote a single figure, so ask each provider and your insurer for the numbers that apply to you.

Side Effects and Safety Considerations

Because both drugs act on the same receptor, their side effects overlap. In Spravato's clinical trials, 48% to 61% of people developed sedation, and 61% to 84% experienced dissociative or perceptual changes, such as distortions of time or space, according to the prescribing information. Dizziness, nausea, vertigo, anxiety, and a temporary rise in blood pressure are also common, which is why blood pressure is rechecked about 40 minutes after dosing. IV ketamine produces the same family of effects, concentrated during and shortly after the infusion.

‍

Direct safety comparisons are limited. In one retrospective analysis included in the Mayo Clinic review, a rise in blood pressure during treatment occurred in 45% of IV ketamine patients versus 9.2% of nasal esketamine patients, and dissociative effects were also more frequent with IV ketamine, though they were described as transient. That is one retrospective study. It doesn't establish either drug as safer overall.

‍

Both drugs carry a potential for misuse, which shapes who is a candidate, and each has its own exclusions. Spravato, for example, isn't used in people with aneurysmal blood vessel disease, an arteriovenous malformation, or a history of bleeding in the brain.

What Influences the Choice Between Them

There isn't a universal right answer. A psychiatrist weighing the two usually considers:

‍

  • Coverage and cost. Whether insurance will cover Spravato in your situation, and whether infusions are affordable out of pocket.
  • How quickly relief is needed. Early data suggest infusions may reach remission in fewer sessions, which matters more when symptoms are severe.
  • Medical history. Blood pressure, vascular conditions, and any history of substance misuse.
  • Route. Some people would rather avoid an IV line. Others prefer an infusion that can be slowed or stopped.
  • Logistics. Spravato means at least two hours in the clinic and no driving until the next day, twice a week at first. Infusions take about 40 minutes, plus recovery time that varies by clinic.
  • Continuity. Whether you're already established with a psychiatrist or clinic that offers one of them.

‍

The choice belongs in a conversation with a psychiatrist who knows your treatment history, not in a ranking of favorites.

Making the Decision With a Psychiatrist

Spravato and ketamine infusions are tools for treatment-resistant depression, not a complete plan. They work alongside medication, therapy, and ongoing psychiatric care, and they sit among other options, including TMS therapy for depression that hasn't responded to medication. When depression brings thoughts of suicide, care for suicidal thoughts comes first.

‍

We don't offer Spravato at Amae. Our psychiatrists treat depression that hasn't responded to medication through our integrated care model, with therapy, medication management, and TMS, which we provide in Los Altos, San Mateo, and Los Angeles. Whether the question is Spravato vs ketamine infusion or something else entirely, talk through your options with an Amae psychiatrist, including ones we don't provide ourselves. For anyone in crisis right now, 988 is a call or text away.

Frequently Asked Questions

Is Spravato more effective than ketamine infusions?

Not on current evidence. A 2025 meta-analysis found no statistically significant difference in response or remission between IV ketamine and nasal esketamine, only a slight numerical trend favoring IV ketamine. Most of that evidence is observational, and a large randomized head-to-head trial is still underway.

Which works faster, Spravato or ketamine infusions?

IV ketamine may reach remission in fewer sessions. In one observational study, the median was two IV infusions versus seven nasal esketamine treatments. Because that finding comes from observational data rather than a randomized trial, treat it as preliminary.

Is Spravato safer than ketamine infusions?

Neither has been established as safer overall. The two share a similar side-effect profile because they act on the same receptor. One retrospective comparison found more blood pressure spikes and dissociation with IV ketamine, but a single study can't settle the question, and individual risk depends on your medical history.

Why is Spravato covered by insurance but ketamine infusions often aren't?

Spravato has FDA approval for treatment-resistant depression, which gives insurers defined criteria for covering it, usually with prior authorization. IV ketamine for depression is off-label, so coverage is inconsistent and infusions are often self-pay.

Can I switch between Spravato and ketamine infusions?

That's a clinical decision to make with a psychiatrist, based on how you've responded, the side effects you've had, your goals, and your coverage. It isn't something to change on your own.

How many sessions does each treatment typically require?

Spravato starts at twice a week for four weeks, then weekly, then weekly or every two weeks based on response. Ketamine infusions often begin with three to six sessions given two to three times a week, followed by maintenance on a schedule that varies by clinic.

‍

Citations

  1. Elmosalamy A, Tarikogullari I, Patarroyo-Rodriguez L, et al. Intravenous ketamine versus esketamine for depression: a systematic review and meta-analysis. Therapeutic Advances in Psychopharmacology. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12615959/
  2. U.S. Food and Drug Administration. SPRAVATO (esketamine) nasal spray prescribing information, revised January 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211243s016lbl.pdf
  3. Wilkinson ST, Prashad S, Dalthorp R, et al. Non-inferiority, comparative effectiveness study of intravenous ketamine v. intranasal esketamine for treatment-resistant depression: the EQUIVALENCE trial protocol. Contemporary Clinical Trials. 2026;164:108273. https://pubmed.ncbi.nlm.nih.gov/41780747/
  4. 988 Suicide and Crisis Lifeline. https://988lifeline.org

‍

# min read

Best Mental Health Clinics in New York City

By

Sonia Garcia

|

September 21, 2026

New York has no shortage of mental health clinics, but volume doesn’t simplify the decision. A public hospital system, a university faculty practice, and a specialized outpatient program are all called clinics, and they serve very different needs. What matters is matching the right type of provider to what you are actually dealing with.

Someone managing mild anxiety needs something very different from someone stabilizing after a first psychotic episode, and New York has clinics built for each. This guide organizes the city’s leading clinics by what they do, then walks through the provider types, levels of care, insurance, and practical steps to get started.

What to Look for in a Mental Health Clinic in NYC

Choosing among outpatient mental health options in NYC gets easier when you hold each clinic up against the same factors:

–  Evidence-based treatment. Look for established approaches: CBT, DBT, medication management, and structured programs like IOP and PHP when the situation calls for them.

–  Team composition. Who delivers care? Psychiatrists, licensed therapists (LCSW, LMHC), and peer support each play a different role. Integrated teams coordinate them.

–  Conditions treated. Some clinics handle complex and co-occurring conditions; others focus on general anxiety and depression. Match the clinic to your diagnosis.

–  Insurance acceptance. Confirm in-network status, and whether the clinic takes Medicaid or Medicare, before booking.

–  Wait times. These range from same-day appointments to months-long waitlists, especially at academic centers.

–  Integrated care. Some clinics coordinate psychiatry, therapy, and primary care under one roof, which matters most for serious or complex conditions where several providers would otherwise be working without talking to each other.

Best Mental Health Clinics in NYC

New York’s clinics fall into distinct categories, each built for a different need: integrated care for serious mental illness, academic medical centers, public safety-net systems, private outpatient practices, and nonprofit community clinics. The best clinic is the one whose category fits your situation, so the providers below are grouped that way rather than ranked against each other. Start by finding the category that matches what you are dealing with, then compare the specifics of insurance, location, and wait time within it.

Details were verified from each provider as of 2026; confirm current specifics directly, since programs and insurance networks change.

Amae Health: Integrated Care for Adult Severe Mental Illness

At our Upper East Side clinic, Amae Health provides integrated outpatient care for adults living with severe and complex mental illness, delivered in collaboration with NewYork-Presbyterian. We treat depression, bipolar disorder, schizophrenia, schizoaffective disorder, PTSD, and co-occurring conditions.

The difference is the team, not any single service. Every patient works with a coordinated group under one roof: psychiatrists, therapists, peer support specialists, health coaches, and primary care. Rather than juggling separate providers who never speak to each other, you work with one team and one treatment plan — which matters most when a condition touches several parts of life at once.

–  Specialties: Depression, bipolar disorder, schizophrenia, schizoaffective disorder, PTSD, co-occurring conditions

–  Care model: Integrated psychiatry, therapy, peer support, and primary care

–  Insurance: Healthfirst, Fidelis Care, and Wellcare; same-day appointments available

–  Best for: Adults with serious or complex mental illness who want fully integrated, psychiatrist-led care

NewYork-Presbyterian: Academic Medical Center Care

NewYork-Presbyterian provides adult outpatient psychiatry through its Weill Cornell and Columbia campuses, covering anxiety, bipolar disorder, depression, and psychosis. For treatment-resistant depression, it offers interventional options including TMS and ketamine. NewYork-Presbyterian-Columbia and Cornell was ranked #3 in the nation for psychiatry by U.S. News & World Report in 2025 (U.S. News Best Hospitals for Psychiatry). Waitlists can be longer.

–  Specialties: Mood, anxiety, and psychotic disorders; treatment-resistant depression

–  Care model: Academic hospital outpatient care with interventional psychiatry

–  Best for: Patients who want academic-center expertise and can wait for intake

ColumbiaDoctors: University Faculty Practice

ColumbiaDoctors is Columbia University’s psychiatry and psychology faculty practice, one of the largest mental health providers in the New York metro area with over 100 clinicians. Beyond standard outpatient care, it runs specialized programs, including the Columbia Day Program, an intensive outpatient clinic in Midtown, a dedicated DBT program, and the Lieber Recovery Clinic for adults with schizophrenia spectrum and other complex conditions.

–  Specialties: Complex and psychotic disorders, emotion dysregulation, substance use

–  Care model: University faculty practice with specialized outpatient and day programs

–  Best for: Patients seeking subspecialty academic care or a specific program like DBT

NYC Health + Hospitals: Public Safety-Net Care

NYC Health + Hospitals is the city’s largest public health system and its largest behavioral health provider, delivering the majority of mental health and substance use care in New York City. Services run across emergency, inpatient, and outpatient settings at public hospitals citywide, including Bellevue, Metropolitan, Elmhurst, and Lincoln, plus a 24/7 Behavioral Health Virtual ExpressCare line for urgent, non-emergency needs.

–  Specialties: The full range of mental health and substance use conditions

–  Care model: Public hospital system, care regardless of immigration status or ability to pay

–  Insurance: Accepts Medicaid; sees all patients regardless of coverage

–  Best for: New Yorkers who need public, low-cost, or uninsured-friendly care

Integrative Psych: Private Outpatient and Ketamine-Assisted Therapy

Integrative Psych is a private Manhattan practice offering psychiatry and therapy for anxiety, depression, ADHD, OCD, and trauma. It combines medication management with evidence-based modalities including CBT, DBT, and EMDR, and offers ketamine-assisted therapy for conditions that have not responded to conventional treatment. An initial consultation precedes any treatment commitment.

–  Specialties: Anxiety, depression, ADHD, OCD, trauma

–  Care model: Private outpatient therapy and psychiatry, with ketamine-assisted therapy

–  Best for: Adults seeking private outpatient care or interventional options for treatment-resistant symptoms

Metropolitan Center for Mental Health: Nonprofit Community Care

Metropolitan Center for Mental Health is a nonprofit outpatient organization founded in 1962, with three Manhattan locations, including Central Park West and Washington Heights. It provides individual, family, couples, and group therapy plus medication management, with a longstanding focus on affordable, community-based care.

–  Specialties: General outpatient mental health across a broad range of conditions

–  Care model: Nonprofit community outpatient clinic

–  Insurance: Accepts Medicaid and Medicare, with sliding-scale fees for the uninsured

–  Best for: New Yorkers seeking affordable, community-based outpatient therapy

Types of Mental Health Providers in NYC

Different providers do different things. Knowing the distinction helps you find the right support faster.

Psychiatrists

Psychiatrists are board-certified physicians who have completed a psychiatry residency. They diagnose mental health conditions, prescribe and manage medication, and sometimes provide therapy. No referral is required to see one. For serious conditions, psychiatric oversight anchors the treatment plan.

Therapists (LCSW, LMHC, Psychologist)

Therapists provide talk therapy, including CBT, DBT, and psychodynamic approaches, but cannot prescribe medication. Many people work with both a therapist and a psychiatrist. Some clinics coordinate the two under one team so the therapy and the medication plan inform each other.

Psychiatric Nurse Practitioners (PMHNP)

Psychiatric-mental health nurse practitioners can diagnose and prescribe in New York State. They often work alongside psychiatrists in integrated care teams, expanding access to evaluation and medication management.

Conditions Treated at Mental Health Clinics in NYC

Most outpatient clinics treat a range of conditions, though some specialize:

–  Major Depressive Disorder. For treatment-resistant cases, a larger academic center or a depression treatment center in New York may offer TMS or ketamine when standard antidepressants have not worked.

–  Bipolar disorder. Best managed at integrated clinics with coordinated psychiatry and therapy.

–  Anxiety disorders, including generalized anxiety, panic, social anxiety, and OCD.

–  PTSD and trauma. Look for clinicians trained in Cognitive Processing Therapy, EMDR, or Prolonged Exposure.

–  Schizophrenia, schizoaffective disorder, and first-episode psychosis. These benefit from specialized IOP programs and structured psychiatric support.

–  Co-occurring conditions. Mental health and substance use are best treated together by an integrated care team rather than in separate silos.

Levels of Outpatient Mental Health Care in New York

Outpatient care comes at different intensities depending on symptoms and support needs.

Standard Outpatient

Usually one session per week with a therapist or psychiatrist. Suited to people managing symptoms while functioning in daily life.

Intensive Outpatient Program (IOP)

Around three days per week, roughly three hours per session, combining group therapy, individual therapy, and psychiatric management. IOP fits people who need more support than weekly sessions.

Partial Hospitalization Program (PHP)

Up to five days per week for several hours per day. SAMHSA defines partial hospitalization as ambulatory care delivered more than three hours per day on more than two days per week (SAMHSA, N-SUMHSS Definitions). PHP is used as a step-down from inpatient care or for acute symptoms. Not every clinic offers it.

CBT and DBT run through all of these levels; both are among the best-studied psychotherapies for mood, anxiety, and emotion-regulation conditions (NIMH, Psychotherapies).

How to Find the Right Mental Health Clinic in NYC

A practical sequence:

1.  Identify what you need. Medication, therapy, or both? Your symptoms and daily functioning point to the level of care.

2.  Check insurance before booking. Confirm in-network status and your copay.

3.  Search by condition, insurance, and location. The Psychology Today therapist directory and SAMHSA’s FindTreatment.gov locator both filter on all three.

4.  Verify the provider’s license. The New York State Office of the Professions lets you confirm a clinician is licensed and in good standing.

5.  Ask about first available appointments. A shorter path to care matters when symptoms are acute.

If you want help thinking through which level of care fits, contact our team.

How Much Does Mental Health Treatment Cost in NYC?

Cost depends heavily on insurance. Under the federal Mental Health Parity and Addiction Equity Act, plans that cover mental health must apply financial terms no more restrictive than those for medical care (CMS, MHPAEA).

With insurance: most plans, including Medicaid and Medicare, cover outpatient mental health. In-network copays typically run $0 to $50 per session.

Without insurance: psychiatrist sessions often run $300 to $500 and therapy $150 to $300, as general ranges rather than quotes. NYC Health + Hospitals and Federally Qualified Health Centers see patients regardless of ability to pay, often on a sliding scale.

Out-of-network: ask the provider for a superbill, a detailed receipt you submit to your insurer for partial reimbursement. Reimbursement rates vary widely by plan, so it helps to ask your insurer what percentage of an out-of-network mental health visit they cover before committing. Our patients and families resources can help you prepare. Confirm every figure with the clinic and your insurer before you begin.

Getting Started

Finding the right clinic is the first step, and it does not have to be the hardest one. If you or someone you love is managing a serious or complex mental health condition, Amae Health’s NYC clinic offers integrated care with psychiatry, therapy, peer support, and primary care under one team, in collaboration with NewYork-Presbyterian. Explore our full range of treatments, or call to talk with our intake team about whether Amae is the right fit for your situation.

Frequently Asked Questions

–  What is the best mental health clinic in NYC? There is no single best clinic; it depends on your condition, the support you need, your insurance, and your location. For complex or serious conditions, Amae Health offers integrated psychiatric care on the Upper East Side. For general therapy or academic subspecialty care, a private practice or university clinic may fit better.

–  What is the difference between a psychiatrist and a therapist? Psychiatrists are medical doctors who diagnose and prescribe medication; therapists provide talk therapy but cannot prescribe. Many people work with both, and some clinics coordinate the two roles under one team.

–  Does insurance cover mental health treatment in NYC? Yes. Most plans, including Medicaid and Medicare, cover outpatient mental health, and parity law requires that coverage to be comparable to medical care. Confirm your copay and in-network status with your insurer before scheduling.

–  What is outpatient mental health treatment? Outpatient treatment is psychiatric care or therapy you receive while living at home. It ranges from weekly standard sessions to more intensive IOP and PHP programs for people who need more structure.

–  How long does it take to get a mental health appointment in NYC? It varies. Hospital systems and academic centers often have longer waitlists, while some clinics offer same-day appointments, including Amae Health. For free 24/7 support, contact NYC 988 by phone, text, or chat at 988.

–  Can I get mental health treatment in NYC without insurance? Yes. NYC Health + Hospitals sees all patients regardless of ability to pay, Federally Qualified Health Centers offer sliding-scale fees, and Medicaid enrollment is open to eligible New Yorkers.

–  What conditions do outpatient mental health clinics in NYC treat? Depression, anxiety, bipolar disorder, PTSD, OCD, schizophrenia, schizoaffective disorder, and co-occurring conditions. Specialties vary by clinic, so confirm a clinic’s experience with your diagnosis before booking.

Citations

1. SAMHSA, National Substance Use and Mental Health Services Survey (N-SUMHSS) Definitions: “Partial hospitalization/day treatment.” info.nsumhss.samhsa.gov/definitions.htm. Tier 2 (U.S. government).

2. National Institute of Mental Health, “Psychotherapies.” nimh.nih.gov/health/topics/psychotherapies. Tier 2 (U.S. government).

3. Centers for Medicare & Medicaid Services, “The Mental Health Parity and Addiction Equity Act (MHPAEA).” cms.gov. Tier 2 (U.S. government).

4. U.S. News & World Report, “Best Hospitals for Psychiatry in New York.” health.usnews.com. Tier 4 (reputable ranking).

‍